Biblio
“Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 1, pp. 247-257, 2020.
, “In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.”, J Alzheimers Dis, vol. 73, no. 1, pp. 147-161, 2020.
, “Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia.”, J Alzheimers Dis, vol. 74, no. 2, pp. 435-439, 2020.
, “Inflammation in Traumatic Brain Injury.”, J Alzheimers Dis, vol. 74, no. 1, pp. 1-28, 2020.
, “Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
, “Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1201-1209, 2020.
, “lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 1, pp. 85-98, 2020.
, “Loss of Functional Dentition is Associated with Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1313-1320, 2020.
, “Metabolic Changes Detected by 18F-FDG PET in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1513-1521, 2020.
, “Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 277-286, 2020.
, “Mitochondrial DNA Manipulations Affect Tau Oligomerization.”, J Alzheimers Dis, vol. 77, no. 1, pp. 149-163, 2020.
, “Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly.”, J Alzheimers Dis, vol. 78, no. 1, pp. 453-465, 2020.
, “Morphometric Analysis of Hippocampal and Neocortical Pyramidal Neurons in a Mouse Model of Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1069-1083, 2020.
, “Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.”, J Alzheimers Dis, 2020.
, “Music Playlists for People with Dementia: Trialing A Guide for Caregivers.”, J Alzheimers Dis, vol. 77, no. 1, pp. 219-226, 2020.
, “A Narrative Review of Alzheimer's Disease Stigma.”, J Alzheimers Dis, vol. 78, no. 2, pp. 515-528, 2020.
, “Neurobiology of COVID-19.”, J Alzheimers Dis, vol. 76, no. 1, pp. 3-19, 2020.
, “Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1279-1294, 2020.
, “Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.”, J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
, “New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
, “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
, “Non-Coding RNAs Based Molecular Links in Type 2 Diabetes, Ischemic Stroke, and Vascular Dementia.”, J Alzheimers Dis, vol. 75, no. 2, pp. 353-383, 2020.
, “Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases.”, J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
, “Novel Markers of Angiogenesis in the Setting of Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 75, no. 3, pp. 959-969, 2020.
, “Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 75, no. 3, pp. 845-854, 2020.
,